Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON38928
NL-OMON38928
Completed
Not Applicable

Effects of the selective mineralocorticoid receptor antagonist eplerenone on extracellular adenosine formation in humans in vivo - eplerenone and adenosine

niversitair Medisch Centrum Sint Radboud0 sites14 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsblood flowischemia reperfusion injury10011082

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
blood flow
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
14
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 24, 2013
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •Healthy, male, age 18\-40 years, written informed consent
  • •(see also chapter 4\.2 (Inclusion criteria) of the protocol)

Exclusion Criteria

  • •smoking, history of cardiovascular disease, hypertension, renal dysfunction, serum potassium \> 4\.7 mmol/L
  • •(see also chapter 4\.3 (Exclusion criteria) of the protocol)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Effects of eplerenone on forearm blood flowhealthy volunteersTherapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
EUCTR2013-000189-12-NLniversity Medical Centre Nijmegen
Completed
Phase 2
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover studyIntradialytic hypotensionMineralocorticoid receptor agonist
TCTR20200128004ampang hospital10
Not yet recruiting
Phase 2
Effects of Mineralocorticoid Receptor Blockade on Metabolism - A Clinical TrialObesityMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - Obesity
ACTRN12618001958279Dr Moe Thuzar32
Active, not recruiting
Phase 1
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors?depressed patients and healthy control subjectsTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2014-005239-15-DECharité - Universitätsmedizin Berlin232
Completed
Not Applicable
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertensiodrug-resistant morning hypertension
JPRN-UMIN000014186Jichi Medical University School of Medicine100